Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arimoclomol in SOD1 Positive Familial ALS
NCT00706147Phase 3Completed
- Sponsor
- University of Miami
- Start
- Jan 2009
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of arimoclomol in amyotrophic lateral sclerosis (ALS), sponsored by University of Miami. Started Jan 2009; status: completed.
02
Drugs
arimoclomol
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00706147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00706147.